The Department of Defense (DoD) has revealed the final group of nine companies selected to participate in its Distributed Bioindustrial Manufacturing Program (DBIMP), a strategically important initiative aimed at strengthening the U.S. bioeconomy and enhancing national defense capabilities.
The selected companies—Amyris, Cauldron Molecules, Checkerspot, DSM Nutritional Products, EVERY Company, The Fynder Group, Liberation Labs, Perfect Day, and Solugen—will receive funding to formulate comprehensive business and technical plans for establishing bioindustrial manufacturing facilities within the United States.
Heidi Shyu, the Under Secretary of Research and Engineering, emphasized the critical role these companies will play in creating a robust network of large-scale production facilities. “This initiative represents a significant step toward fortifying our chemical supply chain and preparing the U.S. bioeconomy for future growth,” Shyu remarked, alluding to the substantial potential of biomanufacturing.
As part of the DBIMP, the awarded companies will develop proposals under the Defense Industrial Base Consortium’s other transaction agreement, which is managed by the Office of the Assistant Secretary of Defense for Industrial Base Policy. Projects that pass the evaluation process could secure funding up to $100 million to support the construction of manufacturing facilities.
This latest group of awardees follows the selection of 25 companies earlier in the program’s initial phase, which allocated more than $60 million for investments in bioindustrial projects. This collaborative effort aims to position the U.S. as a leader in biomanufacturing and advance the nation’s industrial capabilities.
